According to TipRanks.com, Souda is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.6% and a 37.8% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.
Thermo Fisher has an analyst consensus of Strong Buy, with a price target consensus of $649.38, implying a 14.0% upside from current levels. In a report issued on July 13, Barclays also maintained a Buy rating on the stock with a $630.00 price target.
Thermo Fisher’s market cap is currently $224.4B and has a P/E ratio of 29.89.
Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TMO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Read More on TMO:
- Ord Minnett Thinks Macquarie Group Limited’s Stock is Going to Recover
- Stephens Reaffirms Their Buy Rating on Nicolet Bankshares (NIC)
- Investors Cheer for Texas Instruments’ Upbeat Q2 Results
- Nicolet Bankshares (NIC) Gets a Buy Rating from Ladenburg Thalmann & Co.
- Nanosonics Limited (NNCSF) Receives a Sell from Ord Minnett